Cell-culture-derived influenza vaccine production

The Lancet

Volumn 377, Issue 9767, 2011, Pages 698-700

  Glezen, W Paul ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE; INFLUENZA VIRUS HEMAGGLUTININ; PLACEBO; VIRUS ANTIGEN;

CELL CULTURE; INFLUENZA A (H3N2); INFLUENZA A (H5N1); INFLUENZA VIRUS A H5N1; MICROBIAL CONTAMINATION; NONHUMAN; NOTE; PRIORITY JOURNAL; VACCINE PRODUCTION; VERO CELL; VIRUS STRAIN;

EID: 79952068221     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(11)60174-8     Document Type: Note

References (11)

1. Barrett PN, Berezuk G, Fritsch S, et al. Efficacy, safety, and immunogenicity of a Vero-cell-culture-derived trivalent influenza vaccine: a multicentre, double blind, randomised, placebo-controlled study. Lancet 2011; published online Feb 16. DOI:10.1016/S0140-6736(10)62228-3.
2. Jefferson T, Di PC, Rivetti A, et al. Vaccines for preventing influenza in healthy adults. Cochrane Database Syst Rev 2010; 7: CD001269.
3. Wright PF. Vaccine preparedness - are we ready for the next pandemic? N Engl J Med 2008; 358: 2540-43. (Pubitemid 351831355)
4. Rocha EP, Xu X, Hall HE, Allen JR, Regnery HL, Cox NJ. Comparison of 10 influenza A (H1N1 and H3N2) haemagglutinin sequences obtained directly from clinical specimens to those of MDCK cell- and egg-grown viruses. J Gen Virol 1993; 74: 2513-18. (Pubitemid 23332317)
5. Katz JM, Webster RG. Efficacy of inactivated influenza A virus (H3N2) vaccines grown in mammalian cells or embryonated eggs. J Infect Dis 1989; 160: 191-98. (Pubitemid 19189009)
6. Wood JM, Oxford JS, Dunleavy U, Newman RW, Major D, Robertson JS. Influenza A (H1N1) vaccine efficacy in animal models is influenced by two amino acid substitutions in the haemagglutinin molecule. Virology 1989; 171: 214-21. (Pubitemid 19180789)
7. Frey S, Vesikari T, Szymczakiewicz-Multanowska A, et al. Clinical efficacy of cell culture-derived and egg-derived inactivated subunit influenza vaccines in healthy adults. Clin Infect Dis 2010; 51: 997-1004.
8. Koudstaal W, Hartgroves L, Havenga M, et al. Suitability of PER.C6 cells to generate epidemic and pandemic influenza vaccine strains by reverse genetics. Vaccine 2009; 27: 2588-93.
9. Minor PD. Vaccines against seasonal and pandemic influenza and the implications of changes in substrates for virus production. Clin Infect Dis 2010; 50: 560-65.
10. Palache AM, Brands R, van Scharrenburg GJM. Immunogenicity and reactogenicity of influenza subunit vaccines produced in MDCK cells or fertilized eggs. J Infect Dis 1997; 176 (suppl 1): S20-23.
11. Topics & Objectives Index-Healthy People. http://www.healthypeople. gov/2020/topicsobjectives2020/pdfs/HP2020objectives.pdf (accessed Feb 4, 2011).